Exploring the Controversy Over Drug Imports From Canada

The Galen Institute will host a briefing at noon, this Friday (Oct. 17) in Room 106 of the Senate Dirksen Office Building. Allowing Americans to legally import cheaper drugs from Canada is a hot political topic that Medicare conferees and the Senate soon will address. Please join us for a discussion with experts who will explore the issues of safety, research and development, international trade, and the impact on patients today and cures for tomorrow. Speakers will include:


Peter Pitts, Associate Commissioner for External Relations


Food and Drug Administration


Jack Calfee, Resident Scholar

American Enterprise Institute


Stephen Entin, President

Institute for Research on the Economics of Taxation


Carolyn R. Aldige, President and Founder

Cancer Research and Prevention Foundation


Grace-Marie Turner, President, Galen Institute, moderator

SHARE THIS ARTICLE

About the author

The Galen Institute will host a briefing at noon, this Friday (Oct. 17) in Room 106 of the Senate Dirksen Office Building. Allowing Americans to legally import cheaper drugs from Canada is a hot political topic that Medicare conferees and the Senate soon will address. Please join us for a discussion with experts who will explore the issues of safety, research and development, international trade, and the impact on patients today and cures for tomorrow. Speakers will include:


Peter Pitts, Associate Commissioner for External Relations


Food and Drug Administration


Jack Calfee, Resident Scholar

American Enterprise Institute


Stephen Entin, President

Institute for Research on the Economics of Taxation


Carolyn R. Aldige, President and Founder

Cancer Research and Prevention Foundation


Grace-Marie Turner, President, Galen Institute, moderator

SHARE THIS ARTICLE

About the author